MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

HealthDay 13 December at 03.33 PM

Increasing Body Mass Index Tied to 18 Site-Specific Cancers in Men


WEDNESDAY, Dec. 13, 2023 (HealthDay News) -- Increasing body mass index (BMI) at age 18 years is associated with development of subsequent site-specific cancers in men, according to a study published online Nov. 6 in Obesity.

Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined BMI at age 18 years and incident site-specific cancer (malignant melanoma; leukemia; myeloma; Hodgkin lymphoma; non-Hodgkin lymphoma; and cancer in the lungs, head and neck, central nervous system, thyroid, esophagus, stomach, pancreas, liver and gallbladder, colon, rectum, kidney, and bladder) to estimate population attributable fractions due to BMI based on projected obesity prevalence. The analysis included 1.5 million men.

The researchers found that 78,217 men subsequently developed cancer during a mean 31 years of follow-up. There was a linear association between BMI and the risk for developing all 18 site-specific cancers assessed. In some instances, there was an association even with BMI levels usually defined as normal (20 to 25 kg/m2). For prostate cancer, there was an inverse association observed, with higher BMI associated with lower risk. Gastrointestinal cancers had the highest hazard ratios and population attributable fractions.

"If current obesity trends continue, our findings provide additional support for rapid action to stem the course of the obesity epidemic and, with a large prevalence of youth overweight and obesity already in existence, to prepare the health care system for a steeply increasing number of cancer cases,” the authors write.

Abstract/Full Text

#Pediatrics #Gastroenterology #Internal Medicine #Urology #Nephrology #Family Practice #Neurology #Otolaryngology #Pulmonology #Hematology & Oncology #Malignant neoplasm of meninges, unspecified (C70.9) #Malignant melanoma of skin, unspecified (C43.9) #Malignant melanoma of skin (C43) #Malignant melanoma of left lower limb, including hip (C43.72) #Leukemia, unspecified, in remission (C95.91) #Acute leukemia of unspecified cell type not having achieved remission (C95.00) #Multiple myeloma not having achieved remission (C90.00) #Myeloid leukemia, unspecified, not having achieved remission (C92.90) #Hodgkin lymphoma, unspecified (C81.9) #Hodgkin lymphoma, unspecified, lymph nodes of multiple sites (C81.98) #Non-Hodgkin lymphoma, unspecified, unspecified site (C85.90) #Other specified types of non-Hodgkin lymphoma, unspecified site (C85.80) #Malignant neoplasm of unspecified part of unspecified bronchus or lung (C34.90) #Malignant neoplasm of upper lobe, unspecified bronchus or lung (C34.10) #Secondary malignant neoplasm of lung (C78.0) #Personal history of malignant neoplasm of prostate (Z85.46) #Malignant (primary) neoplasm, unspecified (C80.1) #Malignant melanoma of scalp and neck (C43.4) #Malignant melanoma of unspecified part of face (C43.30) #Leukemia, unspecified not having achieved remission (C95.90) #Leukemia, unspecified (C95.9) #Chronic leukemia of unspecified cell type not having achieved remission (C95.10) #Myeloid leukemia, unspecified (C92.9) #Other myeloid leukemia not having achieved remission (C92.Z0) #Hodgkin lymphoma, unspecified, unspecified site (C81.90) #Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck (C81.91) #Mixed cellularity Hodgkin lymphoma, unspecified site (C81.20) #Non-Hodgkin lymphoma, unspecified (C85.9) #Personal history of non-Hodgkin lymphomas (Z85.72) #Secondary malignant neoplasm of unspecified lung (C78.00) #Malignant neoplasm of lower lobe, unspecified bronchus or lung (C34.30) #Malignant neoplasm of prostate (C61) #Overweight (E66.3)

Recent Comments


  • avatar